3-Chloro-4-ethylaniline
![]() |
- $23 - $433
- Product name: 3-Chloro-4-ethylaniline
- CAS: 50775-72-9
- MF: C8H10ClN
- MW: 155.62
- EINECS:
- MDL Number:
- Synonyms:3-Chloro-4-ethylaniline;3-Chloro-4-ethylbenzenamine;Benzenamine, 3-chloro-4-ethyl-;3-CHLORO-4-ETHYLANILINE(WS201512)
5 prices
Selected condition:
Brand
- AK Scientific
- Ambeed
- TRC
Package
- 10mg
- 100mg
- 250mg
- 1g
- ManufacturerAK Scientific
- Product number4251CZ
- Product description3-Chloro-4-ethylaniline
- Packaging100mg
- Price$433
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA841332
- Product description3-Chloro-4-ethylbenzenamine 97+%
- Packaging100mg
- Price$23
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA841332
- Product description3-Chloro-4-ethylbenzenamine 97+%
- Packaging250mg
- Price$41
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA841332
- Product description3-Chloro-4-ethylbenzenamine 97+%
- Packaging1g
- Price$103
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC373785
- Product description3-chloro-4-ethylaniline
- Packaging10mg
- Price$65
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 4251CZ | 3-Chloro-4-ethylaniline | 100mg | $433 | 2021-12-16 | Buy |
Ambeed | A841332 | 3-Chloro-4-ethylbenzenamine 97+% | 100mg | $23 | 2021-12-16 | Buy |
Ambeed | A841332 | 3-Chloro-4-ethylbenzenamine 97+% | 250mg | $41 | 2021-12-16 | Buy |
Ambeed | A841332 | 3-Chloro-4-ethylbenzenamine 97+% | 1g | $103 | 2021-12-16 | Buy |
TRC | C373785 | 3-chloro-4-ethylaniline | 10mg | $65 | 2021-12-16 | Buy |
Properties
storage temp. :under inert gas (nitrogen or Argon) at 2–8 °C
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|